Evaluation of usage of bone scan index in assessment of metastatic prostate cancer

Authors

  • Halil Ćorović Clinic for Nuclear Medicine and Endocrinology, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina
  • Nusret Salkica Clinic for Nuclear Medicine and Endocrinology, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina
  • Safet Hadžimusić Clinic for Nuclear Medicine and Endocrinology, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina
  • Enis Tinjak Clinic for Nuclear Medicine and Endocrinology, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina
  • Adel Brčaninović Clinic for Radiology and Nuclear Medicine of the University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina

DOI:

https://doi.org/10.48026/issn.26373297.2021.12.1.1

Keywords:

Bone scan index, cancer prostate, biomarkers

Abstract

Introduction: Prostate cancer has been the leading type of cancer to affect male population, and as such, it is a subject to efforts to furthermore diagnostic tools already in existence as well as development of new ones which will Aid early diagnostic, treatments as well as a follow up procedures and clinical trials. Bone scan index is a useful and objective biomarker used as a valuable tool for determination as to precise bone involvement in advanced cases, as well as a tool to predict the outcome in prostate cancer patients in clinical trials.
Methods: This paper is a non-experimental (qualitative) research, that is, a scientific review of the literature.
Results: The results we analyzed in this paper were collected from published academic journals.
Conclusion: As a new imaging biomarker, bone scan index has potential to predict therapeutic effects and survival of patients with prostate cancer. Using measurable diagnostic image parameters, the bone scan index is important for determining metastatic bone changes in prostate cancer patients.

Downloads

Published

2021-11-30

How to Cite

1.
Ćorović H, Salkica N, Hadžimusić S, Tinjak E, Brčaninović A. Evaluation of usage of bone scan index in assessment of metastatic prostate cancer. isnn.26373297. [Internet]. 2021Nov.30 [cited 2022May24];12(1):20-6. Available from: https://www.uimr.ba/journal/index.php/rt/article/view/19

Issue

Section

Reviews

Most read articles by the same author(s)